¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"intestinal bacterium"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gram-negative bacterium
    ±×¶÷À½¼º±Õ
  • gram-positive bacterium
    ±×¶÷¾ç¼º±Õ
  • halophilic bacterium
    È£¿°±Õ
  • heterotrophic bacterium
    Ÿ·Â¿µ¾ç±Õ
  • indigenous bacterium
    Åä¹ÚÀ̱Õ
  • mesophilic bacterium
    Á߿±Õ
  • microaerophilic bacterium
    ¹Ì¼¼»ê¼Ò±Õ
  • nitrifying bacterium
    Áú»ê¿°»ý¼º±Õ
  • oral bacterium
    ÀÔ¼Ó±Õ
  • osmophilic bacterium
    »ïÅõ¾Ðģȭ±Õ, °í»ïÅõ¾Ð±Õ
  • pleomorphic bacterium
    ´ÙÇüűÕ, ¹µÇüűÕ
  • prototrophic bacterium
    ±âº»¿µ¾ç±Õ
  • putrefactive bacterium
    ºÎÆÐ±Õ
  • pyogenic bacterium
    °í¸§Çü¼º±Õ, È­³ó±Õ
  • pathogenic bacterium
    º´¿ø¼º±Õ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • enteric bacterium
    âÀÚ¼¼±Õ
  • eugonic bacterium
    ÀßÀÚ¶ó´Â±Õ
  • fusiform bacterium
    ¹æÃß±Õ
  • Gram-negative bacterium
    ±×¶÷À½¼º±Õ
  • Gram-positive bacterium
    ±×¶÷¾ç¼º±Õ
  • halophilic bacterium
    È£¿°±Õ
  • heterotrophic bacterium
    Ÿ·Â¿µ¾ç±Õ
  • indigenous bacterium
    Åä¹ÚÀ̱Õ
  • mesophilic bacterium
    Á߿±Õ
  • microaerophilic bacterium
    ¹Ì»ê¼Ò±Õ
  • nitrifying bacterium
    Áú»ê¿°»ý¼º±Õ
  • oral bacterium
    ÀÔ¼Ó±Õ
  • osmophilic bacterium
    °í»ïÅõ¾Ð±Õ
  • pathogenic bacterium
    º´¿ø±Õ
  • pleomorphic bacterium
    ¹µÇüűÕ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Gram negative bacterium
    ±×¶÷À½¼º±Õ.
  • Gram positive bacterium
    ±×¶÷¾ç¼º±Õ.
  • acid fast bacterium
    Ç×»ê(¼º) ¼¼±Õ.
  • acid fast bacterium
    Ç×»ê(¼º) ¼¼±Õ.
  • acidophil bacterium
    »êÈ£¼º ±Õ(ß«û¿àõж).
  • acidophil bacterium
    »êÈ£¼º ±Õ(ß«û¿àõж).
  • aciduric bacterium
    ³»»ê±Õ(ұ߫ж).
  • aerobic bacterium
    È£±â(¼º)±Õ(û¿Ñ¨àõж).
  • aerotolerant anaerobe bacterium
    ³»±â¼º Çø±â¼¼±Õ, °ø±â°ü¿ë Çø±â¼¼±Õ
  • fusiform bacterium
    ¹æÃß±Õ(Û·õßж).
  • fusiform bacterium
    ¹æÃß±Õ(Û·õßж).
  • halophilic bacterium
    È£¿°(¼º)±Õ(û¿ç¤àõж).
  • heterotrophic bacterium
    Á¾¼Ó¿µ¾ç±Õ.
  • indigenous bacterium
    »óÀç¼¼±Õ(ßÈî¤á¬Ð¶), °íÀ¯¼¼±Õ(ͳêóá¬Ð¶).
  • indigenous bacterium
    »óÀç¼¼±Õ(ßÈî¤á¬Ð¶), °íÀ¯¼¼±Õ(ͳêóá¬Ð¶).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bacterium, Gram-negative
    ±×¶÷À½¼º¼¼±Õ
  • bacterium, Gram-positive
    ±×¶÷¾ç¼º¼¼±Õ
  • bacterium, Gram-variable
    ±×¶÷¿°»ö¼º °¡º¯±Õ
  • bacterium, acid-fast
    Ç×»ê±Õ, Ç׻긷´ë±Õ, AFB
  • bacterium, acidogenic
    »ê»ý»ê¼¼±Õ
  • bacterium, acidophilic(-phil)
    È£»ê¼¼±Õ
  • bacterium, aciduric
    ³»»ê¼º¼¼±Õ
  • bacterium, aerobic
    È£±â±Õ
  • bacterium, anaerobic
    Çø±â±Õ, ¹«»ê¼ÒÁõ½Ä±Õ, ¹«»ê¼Ò¹ßÀ°±Õ
  • bacterium, autotrophic
    Àڷ¿µ¾ç¼¼±Õ, µ¶¸³¿µ¾ç»ý¹°, Àڷ¿µ¾ç»ý¹°
  • bacterium, auxotrophic
    ¿µ¾ç¿ä±¸ º¯À̼¼±Õ
  • bacterium, cariogenic
    Ä¡¾Æ¿ì½ÄÀ¯¹ß¼¼±Õ
  • bacterium, chemolithotrophic
    ¹«±â¿µ¾ç¼¼±Õ
  • bacterium, cold-growing
    Àú¿Â¹ßÀ°¼¼±Õ
  • bacterium, drug resistant
    ¾àÁ¦³»¼º¼¼±Õ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
UGIS Upper Gastro-Intestinal Series
VIP Vasoactive Intestinal (Poly)Peptide
AII acute intestinal infection; second meiotic anaphase
CIA chemiluminescent immunoassay; chymotrypsin inhibitor activity; colony-inhibiting activity; congenita...
CIIP chronic idiopathic intestinal pseudo-obstruction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
G-I Gastro-intestinal
GIT Gastro-intestinal
VIP I-vasoactive intestinal peptide
IPSID Immunoproliferative Small Intestinal Disease
IM Intestinal Metaplasia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • intestinal wall
    À庮
  • juxta-intestinal lymph node
    ¼ÒÀå ¿· ¸²ÇÁ Àý
  • vasoactive intestinal polypeptide
    Ç÷°ü Ȱµ¿¼º Àå°ü Æú¸®ÆéŸÀ̵å
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
megacystitis-microcolon-intestinal hypoperistalsis syndrome <syndrome> A rare condition characterised by abdominal distention, lax abdominal musculature, incomplete intestinal rotation, and deficient intestinal peristalsis. A large bladder and often vesicoureteral reflux are seen. Typically affects female neonates and usually fatal in first year of life.
(05 Mar 2000)
multiple intestinal polyposis Begins usually in late childhood; polyps increase in numbers, causing symptoms of chronic colitis, and carcinoma of the colon almost invariably develops in untreated cases; autosomal dominant inheritance. In the Gardner syndrome there are extracolonic changes (desmoid tumours, etc.).
Synonym: polyposis coli.
Hamartomatous polyposis of the small or large intestine, Peutz-Jeghers syndrome with melanin spots on the lips, less common, miscellaneous, rare, and doubtful occurrences.
Synonym: familial intestinal polyposis.
(05 Mar 2000)
posterior intestinal portal In young embryos, the communications from the midgut to the hindgut.
(05 Mar 2000)
src-related intestinal kinase <enzyme> An intracellular epithelial cell tyrosine kinase; shares 80% homology with human tyrosine kinase brk; has 451 amino acid residues; amino acid sequence given in first source
Registry number: EC 2.7.1.-
Synonym: sik protein, sik gene product
(26 Jun 1999)
neuronal intestinal dysplasia Increased numbers of ganglion cells with myenteric plexus hyperplasia and increased acetylcholinesterase activity in nerves of the mucosa and submucosa. Clinically, neuronal hyperplasia mimics Hirschprung's disease. Similar findings are seen in patients with multiple endocrine neoplasia syndrome, type IIB, and in neurofibromatosis.
Synonym: hyperganglionosis, neuronal intestinal dysplasia.
(05 Mar 2000)
immunoproliferative small intestinal disease A spectrum of conditions ranging from a benign plasma cell hyperplasia to a highly malignant lymphoma of the small intestine.
(12 Dec 1998)
intestinal <anatomy> Pertaining to the intestine.
Origin: L. Intestinalis
(18 Nov 1997)
intestinal 15 kD protein <chemical> From rat ileum; potent lipid-binding protein; mw 15 kD; amino acid sequence given in first source was found to be highly homologous to gastrotropin and rat liver fatty acid-binding proteins; same size transcript also found in ovary; may be involved in metabolism of steroids
Synonym: i-15p
(05 Dec 1998)
intestinal anastomosis Establishment of a new communication between two segments of intestine.
Synonym: enteroanastomosis, intestinal anastomosis.
(05 Mar 2000)
intestinal angina <surgery> A dull, crampy centralised abdominal pain that occurs 15-30 minutes after a meal. Associated with ischaemic bowel disease. Evaluated with mesenteric arteriography.
(27 Sep 1997)
intestinal anthrax A usually fatal form of anthrax marked by chill, high fever, pain in the head, back, and extremities, vomiting, bloody diarrhoea, cardiovascular collapse, and frequently haemorrhages from the mucous membranes and in the skin (petechiae).
See: mycosis intestinalis.
(05 Mar 2000)
intestinal arterial arcades The series of arterial arches formed in the mesentery by anastomoses between adjacent jejunal and ileal arteries and from which vasa recta arise. The arterial arcades of the ileum are shorter and more complex than those of the jejunum.
See: arterial arches of ileum, arterial arches of jejunum.
Synonym: intermesenteric arterial anastomosis, Riolan's arc, Riolan's arcades.
(05 Mar 2000)
intestinal arteries See: ileal arteries, jejunal arteries.
(05 Mar 2000)
intestinal atresia Congenital obliteration of the lumen of the intestine, with the ileum involved in 50% of the cases and the jejunum and duodenum following in frequency. It is the most frequent cause of intestinal obstruction in the newborn infant. Its aetiology may be related to failure of recanalization during early development or to some impairment of blood supply during intrauterine life.
(12 Dec 1998)
intestinal calcium-binding protein <protein> Calcium-binding proteins containing the EF hand motif, induced by vitamin D3.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á